article thumbnail

Reimagining The Future of Pharmacovigilance (PV): Regulations, Tech, Public Perceptions

HIT Consultant

5 At the European level, the European Commission has recently introduced a legislative proposal for a Regulation on Artificial Intelligence (Artificial Intelligence Act) with harmonized rules for the development, placement on the market and use of AI systems in the Union following a proportionate risk-based approach 4. About Barry Mulchrone.

article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy 

Bill Of Health

Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health law and policy issues. Holding Pharmaceutical and Medical Device Executives Accountable as Responsible Corporate Officers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Considerations in payer coverage of digital therapeutics

Healthcare ECONOMIST

One key question is what factors do US payers take into account when evaluating DTx and how does that differ from standard pharmaceuticals. A paper by Gomez Lumbreras et al. 2024) held virtual focus groups with 21 US payers to find the answer. Key considerations include: Need for Evidence.

article thumbnail

Media Mix Transformation for Pharma Marketers: The Power of CTV & Digital Video

HIT Consultant

Lauren Ohlsson, Lead of Industry Solutions, Pharmaceutical and Healthcare, at VDX.tv. Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media. . About Lauren Ohlsson.

article thumbnail

Conclusion to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies

Bill Of Health

Without adequate guidance for how to comply with human rights in the context of public health emergencies, the authors therefore noted that States commonly “exceeded permissible derogations from the ICCPR” and faced “little accountability for their actions whether on domestic or international levels.” Ahmed et al.

article thumbnail

The Case for Procurement Transparency

Bill Of Health

Global health activists and civil society organizations who worked transnationally to curtail what came to be referred to as “vaccine apartheid” faced a pharmaceutical industry that globally relied on secrecy, capital-friendly trade laws, and brute economic force to shirk considerations of human rights.

article thumbnail

A Shared Responsibility Model

Bill Of Health

Several international health law mechanisms, such as the International Health Regulations (IHR) and “ soft law ” frameworks , try to bring together relevant stakeholders to the table, help ensure international sharing of medical information, and facilitate equitable distribution of the benefits of research in developing vaccines and therapeutics.